Cargando…
A rare late progression form of Sly syndrome mucopolysaccharidosis
Mucopolysaccharidoses VII, or Sly syndrome, is linked to mutations in the beta‐glucuronidase encoding gene. Sly syndrome is a rare condition and presentation is highly variable, ranging from a prenatal form with severe, lethal fetal hydrops to more benign adolescent or adult forms with simple thorac...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718110/ https://www.ncbi.nlm.nih.gov/pubmed/31497474 http://dx.doi.org/10.1002/jmd2.12039 |
_version_ | 1783447683474653184 |
---|---|
author | Guffon, Nathalie Froissart, Roseline Fouilhoux, Alain |
author_facet | Guffon, Nathalie Froissart, Roseline Fouilhoux, Alain |
author_sort | Guffon, Nathalie |
collection | PubMed |
description | Mucopolysaccharidoses VII, or Sly syndrome, is linked to mutations in the beta‐glucuronidase encoding gene. Sly syndrome is a rare condition and presentation is highly variable, ranging from a prenatal form with severe, lethal fetal hydrops to more benign adolescent or adult forms with simple thoracic kyphosis. Molecular diagnosis of this adult male patient identified two missense mutations in the GUSB gene that led to a deficiency in beta‐glucuronidase catalytic activity and the resulting accumulation of chondroitin sulfate glycosaminoglycans. During childhood, bilateral inguinal hernia was repaired at 1 year of age and gait abnormalities were noted, leading to a bilateral femoral varization osteotomy due to a bilateral coxa valga with hip subluxation at the age of 7.5. The patient suffered regular upper respiratory infections and required numerous orthopedic surgeries. Despite learning difficulties with visual and hearing deficits, the patient worked full‐time and undertook regular leisure activities. At 33 years of age, the patient's health deteriorated; a hip replacement and glaucoma leading to reductions in his visual field limited his capacity to travel independently. The patient was hospitalized at 51. Although he remained self‐sufficient for taking meals, he needed help with many daily activities. Following a period marked by major asthenia with a general loss of autonomy, the patient died at 52 years of age. With the advent of new enzyme replacement therapies, this medical history of this rare untreated attenuated patient may provide benchmarks to judge the efficacy of treatment in future patients. |
format | Online Article Text |
id | pubmed-6718110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67181102019-09-06 A rare late progression form of Sly syndrome mucopolysaccharidosis Guffon, Nathalie Froissart, Roseline Fouilhoux, Alain JIMD Rep Case Reports Mucopolysaccharidoses VII, or Sly syndrome, is linked to mutations in the beta‐glucuronidase encoding gene. Sly syndrome is a rare condition and presentation is highly variable, ranging from a prenatal form with severe, lethal fetal hydrops to more benign adolescent or adult forms with simple thoracic kyphosis. Molecular diagnosis of this adult male patient identified two missense mutations in the GUSB gene that led to a deficiency in beta‐glucuronidase catalytic activity and the resulting accumulation of chondroitin sulfate glycosaminoglycans. During childhood, bilateral inguinal hernia was repaired at 1 year of age and gait abnormalities were noted, leading to a bilateral femoral varization osteotomy due to a bilateral coxa valga with hip subluxation at the age of 7.5. The patient suffered regular upper respiratory infections and required numerous orthopedic surgeries. Despite learning difficulties with visual and hearing deficits, the patient worked full‐time and undertook regular leisure activities. At 33 years of age, the patient's health deteriorated; a hip replacement and glaucoma leading to reductions in his visual field limited his capacity to travel independently. The patient was hospitalized at 51. Although he remained self‐sufficient for taking meals, he needed help with many daily activities. Following a period marked by major asthenia with a general loss of autonomy, the patient died at 52 years of age. With the advent of new enzyme replacement therapies, this medical history of this rare untreated attenuated patient may provide benchmarks to judge the efficacy of treatment in future patients. John Wiley & Sons, Inc. 2019-07-29 /pmc/articles/PMC6718110/ /pubmed/31497474 http://dx.doi.org/10.1002/jmd2.12039 Text en © 2019 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Guffon, Nathalie Froissart, Roseline Fouilhoux, Alain A rare late progression form of Sly syndrome mucopolysaccharidosis |
title | A rare late progression form of Sly syndrome mucopolysaccharidosis |
title_full | A rare late progression form of Sly syndrome mucopolysaccharidosis |
title_fullStr | A rare late progression form of Sly syndrome mucopolysaccharidosis |
title_full_unstemmed | A rare late progression form of Sly syndrome mucopolysaccharidosis |
title_short | A rare late progression form of Sly syndrome mucopolysaccharidosis |
title_sort | rare late progression form of sly syndrome mucopolysaccharidosis |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718110/ https://www.ncbi.nlm.nih.gov/pubmed/31497474 http://dx.doi.org/10.1002/jmd2.12039 |
work_keys_str_mv | AT guffonnathalie ararelateprogressionformofslysyndromemucopolysaccharidosis AT froissartroseline ararelateprogressionformofslysyndromemucopolysaccharidosis AT fouilhouxalain ararelateprogressionformofslysyndromemucopolysaccharidosis AT guffonnathalie rarelateprogressionformofslysyndromemucopolysaccharidosis AT froissartroseline rarelateprogressionformofslysyndromemucopolysaccharidosis AT fouilhouxalain rarelateprogressionformofslysyndromemucopolysaccharidosis |